ISOZID 0,5 N Pulver zur Herstellung einer Infusionslösung New
Recall
|
Medicines
|
06/08/2025
The marketing authorisation holder informed its customers on August 05, 2025, that during stability testing visible particles have been detected after reconstitution. For this reason, the named batch is being recalled. The medicinal product is authorised in Germany and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.
| Name of the medicinal product | ISOZID 0,5 N Pulver zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | 6192577.00.00 (Deutschland) |
| CIP code | 04250018 (Deutschland) |
| Marketing authorisation holder | Esteve Pharmaceuticals GmbH, DE |
| Manufacturer | Famar Health Care Services, ES |
| Distributor | AGEA Pharma GmbH, AT |
| Batch number(s) | 286480A |
| Expiry date | 04/30/2026 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-5276 |
Further inquiry note
Page last modified:
06/08/2025